Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy

Vaccine

Volumn 27, Issue 18, 2009, Pages 2408-2409

  Roukens, Anna H ^a   Vossen, Ann C ^a   van Dissel, Jaap T ^a   Visser, Leo G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Egg allergy; Intradermal test dose; Yellow fever vaccine

Indexed keywords

ANTIHISTAMINIC AGENT; NEUTRALIZING ANTIBODY; STAMARIL; UNCLASSIFIED DRUG; YELLOW FEVER VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EGG ALLERGY; FEMALE; HUMAN; INJECTION SITE REACTION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN TEST; TONGUE SWELLING; URTICARIA; YELLOW FEVER;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; EGG HYPERSENSITIVITY; FEMALE; HUMANS; INFANT; INJECTIONS, INTRADERMAL; INTRADERMAL TESTS; MALE; MIDDLE AGED; YELLOW FEVER VACCINE;

EID: 62749122187     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.049     Document Type: Article

References (10)

1. Monath T.P. Yellow fever. In: Plotkin S.A., Orenstein W.A., and Paul A. (Eds). Vaccines. 5th ed. (2008), Saunders Elsevier, Philadelphia 959
2. Khromava A.Y., Eidex R.B., Weld L.H., Kohl K.S., Bradshaw R.D., Chen R.T., et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 23 25 (2005) 3256-3263
3. Kelso J.M., Mootrey G.T., and Tsai T.F. Anaphylaxis from yellow fever vaccine. J Allergy Clin Immunol 103 4 (1999) 698-701
4. National Coordination Centre for Traveller's Health (LCR). National guidelines for vaccination and malaria prophylaxis for travellers. Amsterdam: LCR; 2008.
5. Fox J.P., Luty Kossobudski S., and Fonseca da Cunha J. Field studies on the immune response to 17D yellow fever virus. Relation to virus substrain, dose and route of inoculation. Am J Hygiene 38 (1943) 113-138
6. Roukens A.H., Vossen A.C., Bredenbeek P.J., van Dissel J.T., and Visser L.G. Intradermally administered Yellow Fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. PLoS ONE 3 4 (2008) e1993
7. De Madrid A.T., and Porterfield J.S. A simple micro-culture method for the study of group B arboviruses. Bull World Health Organization 40 1 (1969) 113-121
8. Mason R.A., Tauraso N.M., Spertzel R.O., and Ginn R.K. Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine. Appl Microbiol 25 4 (1973) 539-544
9. Lang J., Zuckerman J., Clarke P., et al. Comparison of the immunogenicity and safety of two yellow fever vaccines. Am J Trop Med Hyg 60 6 (1999) 1045-1050
10. McLachlan J.B., Shelburne C.P., Hart J.P., Pizzo S.V., Goyal R., Brooking-Dixon R., Staats H.F., and Abraham S.N. Mast cell activators: a new class of highly effective vaccine adjuvants. Nat Med 14 5 (2008) 536-541